TG Therapeutics Clinical Support Team

Seattle, Washington 98109

We've found

1 trials

at this facility

Study of Pembrolizumab in Combination With Ublituximab and TGR-1202 in Patients With Relapsed-refractory CLL or Richter's Transformation

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Seattle, WA

Use our guide to learn which trials are right for you!